Insider Selling: Docusign (NASDAQ:DOCU) Insider Sells $803,077.60 in Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 16,696 shares of Docusign stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $48.10, for a total transaction of $803,077.60. Following the completion of the sale, the insider owned 72,458 shares in the company, valued at $3,485,229.80. This trade represents a 18.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Docusign Trading Down 1.1%

Shares of DOCU opened at $47.23 on Friday. The stock has a market capitalization of $9.18 billion, a price-to-earnings ratio of 31.91, a PEG ratio of 2.05 and a beta of 1.03. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $94.67. The firm has a fifty day simple moving average of $49.82 and a 200 day simple moving average of $63.96.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The firm had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same period in the previous year, the business earned $0.86 EPS. The company’s revenue was up 7.8% compared to the same quarter last year. As a group, research analysts predict that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has authorized a stock buyback plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to buy up to 21% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Hedge Funds Weigh In On Docusign

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Docusign by 1.1% in the third quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock valued at $1,558,986,000 after buying an additional 225,525 shares during the period. State Street Corp boosted its stake in shares of Docusign by 0.9% during the 4th quarter. State Street Corp now owns 8,193,805 shares of the company’s stock worth $560,456,000 after acquiring an additional 77,008 shares during the period. Capital World Investors increased its holdings in shares of Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after acquiring an additional 1,603,900 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Docusign by 1.6% during the 2nd quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock worth $433,405,000 after acquiring an additional 86,560 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Docusign by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock valued at $278,665,000 after acquiring an additional 18,873 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on DOCU shares. Robert W. Baird reduced their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research report on Wednesday. Morgan Stanley dropped their price objective on Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Cantor Fitzgerald reissued an “outperform” rating on shares of Docusign in a report on Wednesday, December 17th. Jefferies Financial Group cut shares of Docusign from a “buy” rating to a “hold” rating and decreased their target price for the company from $105.00 to $45.00 in a research note on Monday, February 23rd. Finally, Wells Fargo & Company lowered their target price on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a report on Wednesday. Five research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $66.67.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 beat — DocuSign reported Q4 revenue and EPS modestly above consensus and reiterated growth guidance, showing continued subscription momentum and giving a near‑term fundamental support for the stock. Proactive: DocuSign beats Q4 estimates
• Positive Sentiment: Large buyback authorized — The board approved a $2.0 billion increase (bringing total authorization to roughly $2.6B), representing a material portion of market cap; buybacks are a direct capital‑allocation tool that can support the share price and signal management confidence. DocuSign press release: buyback
• Neutral Sentiment: Higher trading volume — Volume spiked after the earnings release, which raises short‑term volatility and can amplify both rebounds and selloffs depending on flow. American Banking News: Volume Increase After Earnings
• Neutral Sentiment: Short‑interest reporting appears inconsistent — March short‑interest entries in the feed show anomalous “0”/NaN values, so there’s no clear short‑flow signal from these data points at this time.
• Negative Sentiment: Analyst cuts and cautious notes — Multiple major brokerages trimmed price targets and moved to more cautious ratings (examples include Morgan Stanley, RBC, UBS, JPMorgan, Piper Sandler, Wells Fargo and others), reducing near‑term upside expectations and contributing to selling pressure. American Banking News: Morgan Stanley Lowers Price Target
• Negative Sentiment: Insider sale disclosed — Senior executive Robert Chatwani sold ~16.7k shares (~$803k); while single insider sales can be routine, the filing has weighed on sentiment alongside the analyst downgrades. SEC Form 4: Insider Sale

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.